DAVITA INC. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
DAVITA INC. (DVA) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of $3.95 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2013-03-01
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2012 was $3.95M, a 78.64% decline from fiscal 2011.
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2011 was $18.50M, a 22183.13% increase from fiscal 2010.
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2010 was $83.00K.
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2008 was $8.24M.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month |
|---|---|
| 2012-12-31 | $3.95M 10-K · filed 2013-03-01 |
| 2011-12-31 | $18.50M 10-K · filed 2013-03-01 |
| 2010-12-31 | $83.00K 10-K · filed 2013-03-01 |
| 2009-12-31 | $1.64M 8-K · filed 2012-07-06 |
| 2008-12-31 | $8.24M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |